argenx SE
F:1AEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
F:1AEA
|
NL |
|
V
|
Verrica Pharmaceuticals Inc
F:1NE
|
US |
|
G
|
General Dynamics Corp
XMUN:GDX
|
US |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
M
|
Marubeni Corp
XMUN:MARA
|
JP |
|
W
|
Wolters Kluwer NV
XMUN:WOSB
|
NL |
|
C
|
Century Casinos Inc
F:CNT
|
US |
|
GoTo Gojek Tokopedia PT Tbk
F:CK8
|
ID |
|
O
|
Oracle Corp
F:ORC
|
US |
Wall St Price Targets
1AEA Price Targets Summary
argenx SE
According to Wall Street analysts, the average 1-year price target for 1AEA is 871.63 EUR with a low forecast of 714.13 EUR and a high forecast of 1 228.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1AEA's stock price target?
Price Target
871.63
EUR
According to Wall Street analysts, the average 1-year price target for 1AEA is 871.63 EUR with a low forecast of 714.13 EUR and a high forecast of 1 228.82 EUR.
What is the Revenue forecast for argenx SE?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 79%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for argenx SE?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 8 years is 26%.
What is the Net Income forecast for argenx SE?
Projected CAGR
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
